secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001826667-25-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus director George Kelly Martin resigns effective April 20, 2025
----------------------------------------------------------------------

- Martin resigned from Board, Audit Committee, and Compensation Committee effective immediately.
- Resignation not due to any disagreement with Company on operations, policies, or practices.
- Company expressed gratitude for Martin's service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000036/0001826667-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000182666725000036/tlsi-20250420.htm
  HTML page:      https://secwatch.observer/filing/0001826667-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer